Krzysztof Matyjaszewski
Fondateur chez Biohybrid Solutions Holding, Inc.
Profil
Krzysztof Matyjaszewski is the founder and former Chief Technology Officer of Pilot Polymer Technologies, Inc. which was founded in 2006.
He is currently a Professor at Carnegie Mellon University.
Dr. Matyjaszewski is also the founder of Biohybrid Solutions Holding, Inc.
Postes actifs de Krzysztof Matyjaszewski
| Sociétés | Poste | Début |
|---|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | Corporate Officer/Principal | 11/03/2010 |
Biohybrid Solutions Holding, Inc.
 Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | Fondateur | - |
Anciens postes connus de Krzysztof Matyjaszewski
| Sociétés | Poste | Fin |
|---|---|---|
Pilot Polymer Technologies, Inc. (Pennsylvania)
 Pilot Polymer Technologies, Inc. (Pennsylvania) Chemicals: SpecialtyProcess Industries Pilot Polymer Technologies, Inc. designs and manufactures specialty polymers. It offers block copolymers, polymeric materials, methacrylates, acrylates, styrenes, vinyl pyridine reagents, ligands and catalyst removal resins. The company was founded by Krzysztof Matyjaszewski, Patrick McCarthy and James Spanswick in 2006 and is headquartered in Pittsburgh, PA. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Pilot Polymer Technologies, Inc. (Pennsylvania)
Pilot Polymer Technologies, Inc. (Pennsylvania) Chemicals: SpecialtyProcess Industries Pilot Polymer Technologies, Inc. designs and manufactures specialty polymers. It offers block copolymers, polymeric materials, methacrylates, acrylates, styrenes, vinyl pyridine reagents, ligands and catalyst removal resins. The company was founded by Krzysztof Matyjaszewski, Patrick McCarthy and James Spanswick in 2006 and is headquartered in Pittsburgh, PA. | Process Industries |
Biohybrid Solutions Holding, Inc.
Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | Health Technology |